Study · verified by the research team
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier JL, Martinez MCM, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL · 2000 · New England Journal of Medicine 342(23): 1686–1692
https://doi.org/10.1056/NEJM200006083422301
Follow-up of Belgian patients with kidney failure after slimming pills in which one herb had been replaced, through a manufacturing error, by nephrotoxic Aristolochia fangchi.
You followed a citation to Abstract. This locator refers to a part of the source not excerpted below; consult the original at the link above.
Study details
| Design | Clinical case series with histology and DNA-adduct analysis |
|---|---|
| Population | 39 patients with end-stage 'Chinese-herb nephropathy' undergoing prophylactic surgery |
| Outcome | Urothelial carcinoma |
| Finding | 18 of 39 (46%) had urothelial carcinoma; aristolochic-acid DNA adducts in all samples; risk rose with cumulative dose |
| Limitations | Single centre; specific to a substitution error, not to correctly identified herbs |
| Certainty | moderate |